Alteration by ␤-amyloid (A␤) of signaling via nicotinic acetylcholine receptors (nAChRs) has been implicated in the early stages of Alzheimer's disease. nAChRs function both post-and presynaptically in the nervous system; however, little is known about the functional consequence of the interaction of A␤ with these receptors, particularly those on presynaptic nerve terminals. In view of the strong correlation between loss of synaptic terminals and dementia, together with the reduction in nAChRs in Alzheimer's disease, the possibility exists that presynaptic nAChRs may be targets for A␤. To explore this possibility, we assessed the effect of A␤ peptides on nicotine-evoked changes in presynaptic Ca 2ϩ level via confocal imaging of isolated presynaptic nerve endings from rat hippocampus and neocortex. A␤ 1-42 appeared to inhibit presynaptic nAChR activation by nicotine. Surprisingly, picomolar A␤ 1-42 was found to directly evoke sustained increases in presynaptic Ca 2ϩ via nAChRs, revealing that the apparent inhibitory action of A␤ 1-42 was the result of an occlusion of nicotine to further stimulate the receptors. The direct effect of A␤ was found to be sensitive to ␣-bungarotoxin, mecamylamine, and dihydro-␤-erythroidine, indicating involvement of ␣7-containing nAChRs and non-␣7-containing nAChRs. Prior depolarization strongly attenuated subsequent A␤-evoked responses in a manner dependent on the amplitude of the initial presynaptic Ca 2ϩ increase, suggesting that nerve activity or Ca 2ϩ channel density may control the impact of A␤ on presynaptic nerve terminal function. Together, these results suggest that the sustained increases in presynaptic Ca 2ϩ evoked by A␤ may underlie disruptions in neuronal signaling via nAChRs in the early stages of Alzheimer's disease.
Introduction
One prominent feature of Alzheimer's disease is the presence of neuritic plaques containing ␤-amyloid (A␤) peptides. A␤ peptides (39 -43 amino acids in length) are generated by proteolytic cleavage of the A␤ precursor protein, a transmembrane glycoprotein present in multiple isoforms (Selkoe, 1998; Walter et al., 2001) . The dominant peptide fragment present within the neuritic plaques, as insoluble fibrils, is the 42-residue species A␤ 1-42 (Iwatsubo et al., 1994; Gravina et al., 1995; Selkoe, 1998) . The A␤ fibrils most likely result from self-aggregation of the A␤ 1-42 (Teplow, 1998; Huang et al., 2000) . There is, however, only a weak correlation between fibrillar A␤ content and cognitive dysfunction (Lue et al., 1999; McLean et al., 1999) . In contrast, the severity of dementia does correlate with the degree of loss of presynaptic terminals (Terry et al., 1991; Sze et al., 1997) as well as with the total load of soluble A␤ (Lue et al., 1999; McLean et al., 1999) . Moreover, transgenic strains exist (e.g., Tg2576) wherein A␤ levels are elevated without plaque formation or nerve cell loss, yet learning and memory deficits are evident (Irizarry et al., 1997; Kotilinek et al., 2002; Westerman et al., 2002) . Consequently, it has been hypothesized that A␤ may be largely acting in a soluble form (dimers and/or small oligomers, also referred to as ADDLs) (Garzon-Rodriguez et al., 1997) to disrupt neuronal signaling (Lambert et al., 1998; Klein et al., 2001 ), particularly at an early stage in Alzheimer's disease, with nicotinic acetylcholine receptors (nAChRs) as a major target . Other possible targets have been suggested, such as microglial scavenger receptors (El Khoury et al., 1998) and the receptor for advanced glycation end products (Lue et al., 2001) .
Evidence for a strong interaction between A␤ and specific nAChRs, particularly ␣7 subunit-containing nAChRs, has accumulated (Dineley et al., 2001; Liu et al., 2001; Pettit et al., 2001; Wang et al., 2000a,b) . Studies examining binding of A␤ to nAChRs expressed on clonal cell lines indicated that A␤ has a picomolar affinity for ␣7-containing nAChRs (Wang et al., 2000a) . In both rat hippocampal slices (Pettit et al., 2001 ) and cultured neurons (Liu et al., 2001) , nanomolar A␤ was shown to inhibit nicotine-evoked currents, including ␣7-AChRs and non-␣7-AChRs, in a reversible, apparently noncompetitive manner. In addition, acute treatment with A␤ was found to activate the MAP kinase cascade in mouse hippocampal slices via ␣7-nAChRs, whereas chronically elevated A␤ in a mouse model of Alzheimer's disease led to downregulation of MAP kinase with concomitant upregulation of ␣7-nAChRs in aged animals (Dineley et al., 2001) . These latter data suggest that A␤ may first activate and then inhibit nAChRs, although no direct activation by A␤ of nAChRs was noted in any of the aforementioned reports using primary tissue.
To determine the consequence of A␤ action on presynaptic nicotinic receptors on nerve terminal signaling, we investigated the effects of A␤ peptides on nicotine-induced Ca 2ϩ responses in individual isolated nerve terminals from rat hippocampus and neocortex.
Materials and Methods
Materials. Synthetic A␤ peptides were purchased from BACHEM (King of Prussia, PA). For all experiments, A␤ peptides were suspended in physiological saline at 100 -1000ϫ stock concentration, thoroughly bath sonicated, and then immediately diluted for use. Under these conditions, the final solutions (picomolar-nanomolar peptide) remain clear, with no visible particles when viewed by phase-contrast microscopy (Lorenzo and Yankner, 1994) , for the course of an experiment (15-30 min). Fluo-3 and fluo-4 were obtained from Molecular Probes, Inc. (Eugene, OR) and are kept as 1 mM stock solutions in DMSO at Ϫ20°C. Cell-Tak was purchased from Collaborative Biomedical Products (Bedford, MA). Nicotine, m-chlorophenyl biguanide, ␣-bungarotoxin, mecamylamine, and dihydro-␤-erythroidine were purchased from Sigma (St. Louis, MO). Conotoxins and agatoxin-TK were purchased from Alomone Labs (Jerusalem, Israel). All drugs and toxins were suspended in physiological saline just before use.
Synaptosome preparation. Hippocampi, striata, or cortices were dissected out of brains from adult male Sprague Dawley rats (Taconic Farms, Germantown, NY) and immediately placed in ice-cold 0.32 M sucrose, following a protocol approved by the Drexel University College of Medicine (formerly MCP Hahnemann University) Institutional Animal Care and Use Committeee. Tissue was then homogenized in 0.32 M sucrose using a glass Teflon tissue grinder. Synaptosomes were isolated according to the method described by Dunkley et al. (1986) . The preparations were washed into oxygenated HEPES-buffered saline [HBS; composition (in mM): 142 NaCl, 2.4 KCl, 1.2 K 2 PO 4 , 1 MgCl 2 , 5 D-glucose, and 10 HEPES, pH 7.4]. This procedure yields synaptosomes, ϳ90% of which have shown to be intact and functional, based on the stability and consistency of Ca 2ϩ responses of dye-loaded synaptosomes to multiple rounds of stimulation as gauged using confocal imaging (Nayak et al., 2000 (Nayak et al., , 2001 .
Calcium imaging. Synaptosomes were loaded with fluorescent Ca 2ϩ indicator dye (fluo-3 or fluo-4) at 5 M by incubating with the acetoxymethyl ester derivative in HBS for 30 -45 min at 37°C. Dye-loaded preparations were washed in HBS containing 1 mM CaCl 2 and then plated onto Cell-Tak-coated coverslips. Relative changes in internal Ca 2ϩ in individual synaptosomes were assessed using confocal imaging (Rondé and Nichols, 1998; Nayak et al., 2001 ) via a Nikon PCM 2000 laser-scanning confocal imaging system connected to a Nikon Diaphot 300 microscope. In brief, the preparations on coverslips were mounted in a rapidexchange Warner (36 l volume) perfusion system attached to the microscope and subjected to perfusion with HBS containing Ca 2ϩ at 3-5 ml/min. Imaging was commenced, and after obtaining a baseline series of five images, stimulatory agents were applied by rapid switching between manifolds on the perfusion system. Complete exchange of the perfusion chamber took place in Ͻ1 sec. Images were typically collected at 4-sec intervals, although in several experiments 15-sec intervals were used. A given experiment corresponded to a series of images captured from a single preparation. The fluorescent intensities associated with a given structure, determined from digitized images using OPTIMAS image analysis software (Optimas Co., Seattle, WA), were expressed as normalized values (F/F 0 ; where F 0 ϭ fluorescence intensity at t 0 ). All time series were corrected for photobleaching.
Statistics. Data sets were compared using matched Student's t tests. Significance was indicated when p was minimally Ͻ0.05.
Results
Nicotine induces robust increases in Ca 2ϩ level in a subpopulation (10 -25%) of isolated nerve terminals (synaptosomes), which slowly decay (several minutes) depending on concentration and receptor subtype (Nayak et al., 2001 . Left graph, n ϭ 45; Right graph, n ϭ 15. Reversibility ( B), concentration dependence ( C), and peptide specificity ( D) of the inhibitory effect of 100 nM A␤ 1-42 were also examined. In D, peptides were present at 100 nM. Note that for A, B, Ca 2ϩ responses to the second stimulation were renormalized (*), although a maintained Ca 2ϩ increase occurred with A␤ (Fig. 3 ). In C,D, data are expressed as percentage of control plateau values (% inhibition). B, n ϭ 13; C: 0 pM, n ϭ 26; 10 pM, n ϭ 8; 100 pM, n ϭ 5; 1 nM, n ϭ 8; D: A␤ 1-42 , n ϭ 73; A␤ 12-28 , n ϭ 15; ЈA␤Ј 40 -1 , n ϭ 6. Hernández et al., 2002) , as well as the closely related 5-HT 3 serotonin receptors when expressed on presynaptic nerve endings Nichols, 1998, 2001) .
Treatment with A␤ 1-42 appeared to strongly inhibit nicotineinduced Ca 2ϩ responses in individual hippocampal synaptosomes in a readily reversible manner ( Fig. 1 A, left) , with the nicotine-induced Ca 2ϩ responses recovering to a significant degree as soon as 30 sec after washing out the A␤ 1-42 ( Fig. 1 B) . The action of A␤ 1-42 on nicotinic receptors present on the presynaptic terminals appears to be specific, because it had no significant effect on presynaptic 5-HT 3 serotonin receptor-induced Ca 2ϩ responses in the same synaptosomes ( Fig. 1 A, right) , as assessed using the highly selective 5-HT 3 receptor agonist m-chlorophenyl biguanide. The latter conclusion was made based on the finding that 5-HT 3 serotonin receptors colocalize with nicotinic receptors at presynaptic sites (Nayak et al., 2000) . The lack of significant effect of A␤ 1-42 on 5-HT 3 receptors is also consistent with previous reports (Wang et al., 2000a; Liu et al., 2001 ). In addition, A␤ 1-42 has been shown to have no effect on glutamate receptors in a hippocampal preparation (Pettit et al., 2001 ). The inhibitory effect of A␤ 1-42 was concentration dependent, with low nanomolar levels producing near complete blockade of the nicotineinduced Ca 2ϩ responses, whereas significant inhibition was evident down into the picomolar range (IC 50 , ϳ10 pM; Fig. 1C ). Finally, a control peptide having a reversed sequence (40 -1; ЈA␤Ј 40 -1 used at 100 nM) from that of A␤ 1-42 had no significant effect on nicotine-induced Ca 2ϩ responses in the hippocampal synaptosomes (Fig. 1 D) . In contrast, 100 nM A␤ 12-28 was nearly as effective as 100 nM A␤ 1-42 in inhibiting the nicotine-induced responses (Fig. 1 D) . A␤ 12-28 was previously shown to interact strongly with ␣7-nAChRs (Wang et al., 2000b) , suggesting that it may contain the nicotinic receptor-binding motif of the A␤ peptides. A␤ 12-28 was also shown to block nicotine-induced currents in hippocampal neurons, as, if not more, effectively as A␤ 1-42 (Pettit et al., 2001 ). These results indicate that presynaptic nicotinic receptors are selectively inhibited by soluble A␤. However, because each Ca 2ϩ response is normalized to baseline, the question arises as to whether A␤ has a direct effect on presynaptic Ca 2ϩ levels, resulting in an occlusion of the nicotine-induced Ca 2ϩ responses, in contrast to direct inhibition of the presynaptic nicotinic receptor. As described later, the inhibitory effect of A␤ was indeed because of an occlusion, i.e., full activation of the nAChRs, preventing further activation by nicotine.
Nicotine-induced Ca 2ϩ responses in a subset of hippocampal synaptosomes (12 Ϯ 6% SD) seem to involve both ␣7-containing nAChRs and non-␣7-containing nAChRs (Fig. 2 A) , as gauged by sensitivity of the responses to various nicotinic receptor antagonists (␣7, ␣-bungarotoxin; non-␣7, dihydro-␤-erythroidine or mecamylamine), consistent with studies of nicotine-induced neurotransmitter release (Clarke and Reuben, 1996; Gray et al., 1996; Radcliffe et al., 1999; Fabian-Fine et al., 2001; Kulak et al., 2001) . The profiles of sensitivity of presynaptic nicotine-induced Ca 2ϩ responses were similar between hippocampal and cortical synaptosomes (data not shown). Interestingly, the apparent inhibitory effect of A␤ 1-42 was more pronounced with hippocampal and cortical synaptosomes as compared with striatal synaptosomes (Fig. 2 B) . Although A␤ has been shown to inhibit non-␣7-containing nAChRs (Pettit et al., 2001) , it displays the highest affinity for ␣7-containing nAChRs (Wang et al., 2000b) , and ␣7-containing nAChRs appear to be a minor presence, at best, on striatal nerve terminals (Nayak et al., 2000; cf. Marchi et al., 2002) , perhaps explaining the much smaller effect of A␤ 1-42 on striatal synaptosomes, particularly when used at 100 pM. Evidence for involvement of ␣7-containing nAChRs on hippocampal synaptosomes is indicated by ␣-bungarotoxin sensitivity of direct effects of A␤ 1-42 to increase synaptosomal Ca 2ϩ (Fig. 5 ). A␤ 1-42 was found to induce directly substantial increases in Ca 2ϩ level (Fig. 3 ) in a subset of hippocampal synaptosomes (17 Ϯ 10% SD), with sustained elevation in Ca 2ϩ level evident for over 10 min of incubation (Fig. 3A) . A␤ 1-42 -induced synaptosomal Ca 2ϩ responses were comparable in number and average magnitude to those evoked by nicotine stimulation. The direct effect of A␤ 1-42 was concentration dependent, with measurable responses in the low picomolar range (Fig. 3C) . Similar findings were obtained using cortical synaptosomes; however, the increases in Ca 2ϩ level in response to 100 pM A␤ 1-42 (F/F 0 , 1.13 Ϯ 0.03 SEM; n ϭ 23) were substantially lower than those seen in response to 100 nM A␤ 1-42 (F/F 0 , 1.45 Ϯ 0.03 SEM; n ϭ 30), in contrast to what was observed for A␤ 1-42 -evoked responses in hippocampal synaptosomes at these same concentrations, indicating a significantly lower potency of A␤ for cortical presynaptic terminals. These direct effects of A␤ were unaltered by filtration of the A␤ 1-42 -containing HBS perfusion solution (Fig. 3E) , indicating that the A␤ was not acting via an aggregated form. A␤ [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] was also able to induce directly increases in synaptosomal Ca 2ϩ (Fig. 3B) . Interestingly, synaptosomal Ca 2ϩ responses to picomolar A␤ 1-42 were dependent on external Ca 2ϩ , whereas they were only partially dependent on external Ca 2ϩ for concentrations of A␤ 1-42 in the high nanomolar to micromolar range (Fig.  4 A) . However, Zn 2ϩ (50 M), known to block alleged A␤ chan- Figure 2 . Sensitivity of nicotine-evoked presynaptic Ca 2ϩ increases to various nicotinic antagonists and to A␤ for preparations from various regions of the brain. A, Average maximal Ca 2ϩ responses to 500 nM nicotine in hippocampal synaptosomes in the absence (n ϭ 34) or presence of 5 M dihydro-␤-erythroidine (DH␤E; n ϭ 26), 500 nM ␣-bungarotoxin (BgTx; n ϭ 9), 10 M mecamylamine (Mec; n ϭ 18), or BgTx plus Mec (n ϭ 11) during the second stimulation, using the successive stimulation protocol described in the legend to Figure 1 . B, Inhibitory effects of 100 nM A␤ 1-42 on nicotine-evoked Ca 2ϩ responses in synaptosomes from hippocampus (Hippo; n ϭ 17), cortex (CTX; n ϭ 13), or striatum (Str; n ϭ 10). Qualitatively similar results were obtained using 100 pM A␤ 1-42 . *p Ͻ 0.05; t test with paired control.
nels that form at relatively high (micromolar) concentrations of A␤ 1-42 (Lin et al., 2001) , had no effect on synaptosomal Ca 2ϩ responses to A␤ 1-42 at any concentration (Fig. 3D) . Moreover, the stimulatory effect of A␤ 1-42 was partially dependent on voltage-gated Ca 2ϩ channels at 100 pM but not at 100 nM (Fig.  4 B) (data not shown). The relative sensitivity of nicotine-induced Ca 2ϩ responses to Ca 2ϩ blockers was similar to that seen for 100 pM A␤ 1-42 -induced responses (data not shown). Finally, the direct effect of A␤ 1-42 was sensitive to ␣-bungarotoxin (Fig. 5A) , the open-channel blocker mecamylamine (Fig. 5B) , and dihydro-␤-erythroidine (Fig. 5D) , to extents comparable with the inhibitory effects of these nicotinic antagonists on nicotine-induced Ca 2ϩ responses (compare Fig. 2) , indicating a significant involvement of ␣7-containing nAChRs and non-␣7-containing nAChRs. Interestingly, the effect of ␣-bungarotoxin was more pronounced when A␤ 1-42 was used at 100 pM, whereas the effect of dihydro-␤-erythroidine was more pronounced when A␤ 1-42 was used at 100 nM. Combining ␣-bungarotoxin with mecamylamine led to an inhibition profile similar to that of ␣-bungarotoxin alone (Fig. 5C ). These results indicate that soluble A␤ at picomolar concentration directly activates presynaptic nAChRs predominantly of the ␣7-containing subtype to increase nerve terminal Ca 2ϩ in a manner dependent on entry of Ca 2ϩ through both the nAChR receptor channel and voltage-gated Ca 2ϩ channels, whereas soluble A␤ at nanomolar concentration directly activates presynaptic nAChRs predominantly of the non-␣7-containing subtype to increase nerve terminal Ca 2ϩ largely via the nAChR receptor channel.
Because the apparent inhibitory effect of A␤ 1-42 on nicotine-induced responses (Fig. 1) was observed under conditions in which each response was necessarily normalized to the initial baseline, owing to uncertainty over baseline values after extended treatment periods without imaging, sequential addition of A␤ and nicotine was performed while imaging. The addition of 500 nM nicotine just after the initial application of A␤ 1-42 to hippocampal synaptosomes resulted in no further increase in Ca 2ϩ level over that obtained in response to A␤ 1-42 alone (Fig. 6 A) , indicating that A␤ 1-42 strongly attenuates Ca 2ϩ responses to nanomolar concentrations of nicotine in these nerve endings. In contrast, increasing nicotine to the micromolar range revealed nicotine-induced Ca 2ϩ responses on top of the initial A␤ 1-42 -induced responses. The control reverse peptide, ЈA␤Ј 40 -1 , caused no significant change in the synaptosomal Ca 2ϩ level and did not significantly inhibit responses to nicotine added on top of the ЈA␤Ј 40 -1 (Fig. 6 A) . Likewise, the addition of A␤ 1-42 just after the initial application of 500 nM nicotine had no significant effect on nicotine-induced Ca 2ϩ responses when applied at 10 pM to 1 nM on top of nicotine, but it did increase synaptosomal Ca 2ϩ when applied at 10 -100 nM (Fig.  6C,D) . In either case, in which relatively high concentrations of the second stimulatory agent were used (Fig. 3C) , all synaptosomes responding to A␤ also responded to nicotine. Taken together, these results indicate that activation of presynaptic nicotinic receptors by picomolar A␤ 1-42 occludes the action of nicotine on the same receptors when applied at typical maximal concentration (500 nM) and vice versa. That the occlusion was not the result of a saturating Ca 2ϩ response or dye saturation is evident in the ability of elevated concentrations to elicit responses (Fig. 6 B, D) . Thus, the apparent inhibitory effect of A␤ on nicotine-induced Ca 2ϩ responses (Fig. 1 ) was a consequence of prior activation of the nAChRs by A␤.
Prior depolarization with elevated external K ϩ resulted in significant attenuation of subsequent A␤ 1-42 -evoked Ca 2ϩ responses (Fig. 7A ) in a manner that was dependent on the amplitude of the initial K ϩ -evoked response (Fig. 7B) . Under any condition, application of 30 mM (or higher) KCl will substantially depolarize all of the synaptosomes in the preparation; however, a wide range of response amplitudes are observed (cf. Nichols and Mollard, 1996) . When Ca 2ϩ responses were first evoked with A␤ 1-42 and followed by subsequent depolarization, the K ϩ -evoked Ca 2ϩ responses were correspondingly attenuated (Fig.  7C ) in a manner somewhat dependent on the amplitude of the initial A␤ 1-42 -evoked response (Fig. 7D) Fig. 7A ). These results suggest that the effect of nerve activity on presynaptic responses to A␤ is strictly dependent on the extent of the increase in Ca 2ϩ level in response to presynaptic depolarization. In contrast, the presence of A␤ can attenuate presynaptic Ca 2ϩ increases in response to nerve activity. To some degree, these effects may have resulted from prior activation of voltage-gated Ca 2ϩ channels by either K ϩ depolarization or A␤-induced depolarization via nAChRs, with the contribution of voltage-gated Ca 2ϩ channels to the evoked Ca 2ϩ signals varying widely across synaptosomes (Nichols and Mollard, 1996) .
Discussion
A␤ accumulates in plaques near dystrophic neurites and nerve endings (Brendza et al., 2003) . Moreover, synaptic loss is strongly correlated with severity of dementia (Terry et al., 1991; Sze et al., 1997) . As yet, effects of A␤ on the presynaptic nerve terminal have not been defined clearly. The present study undertook to explore the possibility that soluble A␤ peptide may modulate presynaptic Ca 2ϩ levels, evaluating first effects on nicotineinduced responses, as an extension of previous work demonstrating an inhibitory interaction between A␤ and nAChRs, and later direct effects of A␤ itself. The observed sustained increases in presynaptic Ca 2ϩ in response to soluble A␤ 1-42 raise the question as to whether such an effect would ultimately be toxic. Interestingly, prior depolarization attenuated the effect of A␤, indicating that the degree of nerve activity and/or relative density of voltagegated Ca 2ϩ channels on the nerve endings may also play a role in modulating the action of soluble A␤ at presynaptic sites, in particular its toxicity.
Several previous reports have demonstrated an action of soluble A␤ peptides on nicotinic receptors (Dineley et al., 2001; Liu et al., 2001; Pettit et al., 2001 ). In particular, A␤ was found to block nicotine-stimulated increases in spontaneous neurotransmitter release from cultured hippocampal neurons (Liu et al., 2001) , as the first clear indication of an action of A␤ on presynaptic nAChRs. In contrast, a recent report demonstrates a direct activation of nAChR-mediated currents in an oocyte expression (Rondé and Nichols, 1998) . *p Ͻ 0.05; t test with paired control. Figure 5 . Sensitivity of A␤-evoked Ca 2ϩ increases in isolated hippocampal nerve endings to nicotinic receptor antagonists. Average maximal responses Ca 2ϩ responses to A␤ 1-42 in the absence or presence of 500 nM ␣-bungarotoxin (BgTx; A) (100 pM, n ϭ 14; 100 nM, n ϭ 22), 10 M mecamylamine (Mec; B) (100 pM, n ϭ 14; 100 nM, n ϭ 14), 500 nM ␣-bungarotoxin plus 10 M mecamylamine (Bg/Mec; C) (100 pM, n ϭ 12; 100 nM, n ϭ 6), or 5 M dihydro-␤-erythroidine (DH␤E; D) (100 pM, n ϭ 22; 100 nM, n ϭ 16). *p Ͻ 0.05; t test with paired control.
system by A␤ (Dineley et al., 2002) . Our work confirms and extends these previous findings, showing specifically that A␤ can directly induce increases in presynaptic Ca 2ϩ . At picomolar A␤ concentration, the resultant Ca 2ϩ responses appeared to largely involve ␣7-containing nAChRs, owing to the sensitivity of the Ca 2ϩ responses to nicotinic antagonist ␣-bungarotoxin. Interestingly, however, prior treatment with A␤ inhibited subsequent action of high nanomolar nicotine, a typical maximal concentration for presynaptic nAChR-evoked responses (Nayak et al., 2001) , by occlusion. That relatively high concentrations of nicotine could overcome, to some degree, the occlusion effect of A␤, in the same synaptosomes, also confirms the involvement of nAChRs. Under the conditions used, these experiments cannot distinguish whether the action of A␤ is competitive or noncompetitive at presynaptic nAChRs, however, but do indicate significant overlap with the ␣-bungarotoxin site in the case of ␣7-nAChRs. Previous results indicated that A␤ may be noncompetitive for acetylcholine (Liu et al., 2001) , which is consistent with findings of at least two binding sites for A␤ on ␣7-nAChRs in ligand-binding studies (Wang et al., 2000b) , and the results presented here do not exclude this possibility. Further study will be needed to determine how A␤ specifically interacts with presynaptic nAChRs.
Although ␣7-containing nAChRs seem to be largely involved in the presynaptic actions of A␤ at picomolar concentration, the results indicate that the action of A␤ when present at high nanomolar concentration on presynaptic Ca 2ϩ may be largely at non-␣7-containing nAChRs, owing to a more pronounced sensitivity of the responses to the nicotinic antagonist dihydro-␤-erythroidine. The results demonstrating that relatively high concentration of A␤ can overcome the occlusion by nicotine of the action of picomolar levels of A␤ are, in contrast, not inconsistent with the possibility that A␤ may be activating a pathway in the nerve endings that is independent of nAChRs. Other indications of direct stimulatory effects of A␤ that are most likely independent of nicotinic receptors have also been noted. For example, A␤ peptide was found to evoke a nonselective inward ion current in rat cortical neurons (Furukawa et al., 1994) . The A␤ peptide-induced current was proposed to have resulted from the formation of cation channels, reported previously, wherein A␤ was used at particularly elevated concentrations (micromolar) (Lin et al., 2001) . Here, however, A␤ induced increases in presynaptic Ca 2ϩ in a reversible manner that was insensitive to Zn 2ϩ , ruling out formation of channels.
An important question is whether A␤-induced alterations in presynaptic Ca 2ϩ affect the release of neurotransmitter. In one study, A␤ was actually found to have an inhibitory effect on K ϩ -evoked acetylcholine release from hippocampal slices (Kar et al., 1996 , although the time frame of these measurements was rather extended. In view of the sustained increases in presynaptic Ca 2ϩ in response to A␤ that were observed here, it may be that neurotransmitter release evoked subsequent to A␤ treatment would be inhibited perhaps as a consequence of a longer-term depressive and/or toxic effect on the nerve terminal. In contrast, it would be predicted that neurotransmitter release would be initially evoked by A␤ as a result of the increased presynaptic Ca 2ϩ . Previous observations of an inhibitory effect of A␤ peptide on nicotine-stimulated increases in spontaneous neurotransmitter release in cultured hippocampal neurons did not, however, note a direct effect of A␤ alone (Liu et al., 2001) . Effects, or lack thereof, of A␤ on exocytosis in individual nerve terminals from brain would require imaging using, for example, amphipathic fluorescent dyes such as FM1-43 (Rondé and Nichols, 1998) .
Another issue is whether sustained presynaptic Ca 2ϩ in response to A␤ will activate certain intracellular signaling pathways, such as protein kinases. Previous observations using hippocampal slices demonstrated extracellular signal-regulated kinase (ERK) activation in response to A␤ (Dineley et al., 2001) . Whether A␤ activates protein kinase pathways, such as ERK, in the presynaptic nerve terminal is currently under investigation.
Despite several lines of evidence, including our own, indicating the possibility of a direct interaction between A␤ and nAChRs, such an interaction remains to be proven. It remains possible that A␤ interacts with a protein that associates with . Averaged responses in A (n ϭ 6) and C (n ϭ 13) are means Ϯ SEM. Averaged maximal responses in B (500 nM, n ϭ 2; 5 M, n ϭ 4; 50 M, n ϭ 3; 200 M, n ϭ 5) and D (10 pM, n ϭ 14; 1 nM, n ϭ 9; 10 nM, n ϭ 9; 100 nM, n ϭ 8) denote the second agent as a percentage of the maximal response to the first agent. Insets, Representative responses. nAChRs and perhaps other signaling molecules. In contrast, nicotinic antagonists were able to inhibit A␤-evoked presynaptic Ca 2ϩ increases, indicating, as noted previously, some overlap of A␤ interaction with the ligand binding site(s). Sorting out the actual presynaptic targets for A␤ will entail a series of detailed molecular studies using, for example, preparations containing nAChRs modified by site-directed mutagenesis, especially in view of differences noted in the structural components of nAChRs that are essential for agonist binding as compared with antagonist binding (Arias, 1997) .
Although speculative at present, our results might suggest that as A␤ begins to accumulate near synaptic sites, nicotinemediated presynaptic regulation will be initially disrupted, although in a manner dependent on nerve activity-coupled presynaptic Ca 2ϩ changes. Nicotinic receptors, particularly presynaptic nAChRs, have been implicated in long-term potentiation in the hippocampus (Fujii et al., 1999; Matsuyama et al., 2000) as well as the ventral tegmental area (Mansvelder and McGehee, 2000) , and, thus, A␤ disruption of signaling via these receptors could have consequences for cognitive function. As A␤ further accumulates, toxic effects on nerve terminals may arise. For example, prolonged A␤ has been shown to alter nerve terminal mitochondrial function (Mattson et al., 1998) . A key question is to what extent such toxicity might be a consequence of sustained presynaptic Ca 2ϩ as compared with A␤ gaining entry into the nerve terminal (Kienlen-Campard et al., 2002; Nagele et al., 2002) . It is likely that disruption of neuronal function at multiple levels via several pathways ultimately underlies the pathology arising over the course of Alzheimer's disease. Figure 7 . Ca 2ϩ responses in isolated hippocampal nerve endings to A␤ after prior depolarization by KCl compared with Ca 2ϩ responses to depolarization by KCl after A␤. The averaged responses in A (n ϭ 26) and C (n ϭ 18) are means Ϯ SEM. Individual peak responses to the second agent in B (n ϭ 71) and D (n ϭ 16) are correlated to the initial peak responses of the first agent, with each response to the second agent normalized to the response to the first agent as a percentage.
